News

CVS Caremark will stop covering Eli Lilly’s Zepbound. Wegovy, the GLP-1 medication to treat obesity from Lilly competitor ...
Another major insurance change coming next year will affect another large swath of Dushay’s patients: In January, BCBS ...
Wegovy, a weight loss drug made famous by celebrities around the world, is on New Zealand pharmacists' shelves, but it is ...
Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...
Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone. Ozempic for blood sugar control and Wegovy for weight loss both use different ...
WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...
Nearly 90 percent of Dutch citizens believe that obesity medication should be covered by the basic health insurance package, ...
Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
Novo Nordisk just killed its deal with Hims & Hers. But Hims might come out stronger after this development. Read why the ...
Thinking about slimming injections like Ozempic or Wegovy? The UK is seeing a surge in cases of acute pancreatitis linked to ...
Senate To Begin Marathon Vote Series On Trump's "Big, Beautiful Bill" As GOP Eyes July 4 Deadline The Senate is set to kick off what's expected to be a marathon session Monday, after the chamber ...
Plastic surgery trends show growing acceptance of aesthetic procedures as self-care, with over 28.5 million minimally ...